Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.62 |
| ▸ | JAK2 | O60674 | 1/20 | 0.61 |
| ▸ | TYK2 | P29597 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | STAT3 | P40763 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.58 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28829404 | 0.95 | KDM4E (0.81) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL27880186 | 0.90 | POLB (0.73) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL19242053 | 0.89 | GAA (1.00) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL13210699 | 0.89 | KMT2A (0.73) | GAAKDM4EL3MBTL1POLBMAPT | |
| SCHEMBL8770686 | 0.85 | GAA (0.85) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL14716526 | 0.85 | KDM4E (1.00) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL1898755 | 0.85 | GAA (0.91) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL6990840 | 0.84 | GAA (0.81) | GAAKDM4EL3MBTL1MAPK1HTT | |
| SCHEMBL3462289 | 0.84 | MDM2 (0.70) | GAAKDM4EL3MBTL1POLBMAPT | |
| SCHEMBL3093559 | 0.84 | GAA (0.81) | GAAKDM4EL3MBTL1MAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234377-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | EVOTEC AG (DE) | 2010-09-16 | — | — | US | claimed |
| EP-2150532-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | Evotec AG (DE) | 2010-02-10 | — | — | EP | claimed |
| WO-2008122787-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | EVOTEC AG (DE) | 2008-10-16 | — | — | WO | claimed |
| US-10350225-B1 | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase | NANT HOLDINGS IP, LLC (US) | 2019-07-16 | — | — | US | disclosed |
| US-9315464-B1 | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase | NANT HOLDINGS IP, LLC (US) | 2016-04-19 | — | — | US | disclosed |
| US-9315464-B1 | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase | NANT HOLDINGS IP, LLC (US) | 2016-04-19 | — | — | US | disclosed |
| US-20100234377-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | EVOTEC AG (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-2150532-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | Evotec AG (DE) | 2010-02-10 | — | — | EP | disclosed |
| WO-2008122787-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | EVOTEC AG (DE) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10350225-B1 | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase | RNGTT, MED23, MED25 | GAA 1669/4885KDM4E 1204/4885L3MBTL1 318/4885 |
| US-20100234377-A1 | PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE | HPGDS, PTGDR, PTGIS | GAA 1250/4885KDM4E 3580/4885L3MBTL1 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.